The company is introducing OM1 Orion, OM1 Lyra, and OM1 Polaris, aligning AI technology and real-world data to offer unprecedented insights into the patient...
QIAGEN announced the availability of QCI Secondary Analysis, a cloud-based software-as-a-services (SaaS) solution enabling high-throughput secondary analysis for use with any clinical next-generation sequencing...
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, announced the first commercial placement of the REM-I platform at...
This end-to-end offering for bespoke RWE projects uses artificial intelligence (AI) to generate fit-for-purpose, analysis-ready clinical data sets months faster and reduces the burden...
VantAI will leverage its proprietary large scale structural data and NVIDIA H100 GPUs on Google Cloud to enable a step-change in accuracy for all-atom...
Oncotelic Therapeutics, Inc., announced that it has entered into a binding term-sheet with Mosaic ImmunoEngineering, Inc. under which Mosaic will acquire rights to Oncotelic’s...
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announced the promotion of James J. Barry, currently Senior Vice...